AHA to MedPAC Re: Rising Pharmaceutical Costs

AHA commends MedPAC and HHS for voicing significant concerns about rising pharmaceutical costs. 

Key Resources

Related Resources

Letter/Comment
AHA to MedPAC Re: Physician Fee Schedule Payments, A-APM Incentives and Medicare Advantage Network Adequacy
Public
Special Bulletin
Special Bulletin: CMS Issues Proposed Rule for CY 2026 Medicare Advantage, Prescription Drug Plans
Member
Letter/Comment
AHA Comments to CMS on FY 2025 Wage Index Values
Letter/Comment
AHA, Others Urge Congress to Extend Medicare Advanced Alternative Payment Model in End-of-year Legislative Package
Public
Letter/Comment
AHA Responds to CMS Medicare Advantage Data and Audit Proposed Protocol
Public
Advisory
CMS Finalizes Medicare Appeal Rights for Certain Changes in Patient Status
Member